Literature DB >> 29671250

Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases.

Carlos K H Wong1, Edmond P H Choi2, Y C Woo3, Brian H H Lang4.   

Abstract

PURPOSE: To evaluate the validity and reliability of a newly-translated Thyroid-specific Patient-Reported Outcome short-form (ThyPRO-39) instrument for ethnic-Chinese patients suffering from benign thyroid diseases.
METHODS: The translation and cross-cultural adaptation of the English ThyPRO-39 were performed using the double forward translation, reconciliation, single backward translation, and cognitive debriefing, followed by a panel review. Cross-sectional data of 308 patients with benign thyroid diseases were utilized for this psychometric evaluation of ThyPRO-39 instrument. Convergent validity between similar construct in the ThyPRO-39, SF-6D, and SF-12v2 was assessed using Spearman correlations. The internal construct validity was assessed by corrected item-total correlations. Sensitivity of the ThyPRO-39 domain scores was determined by performing known group comparisons by independent t test. The internal consistency reliability was assessed by Cronbach's alpha coefficient.
RESULTS: Significant floor effects were observed in 9 out of 13 domains of the ThyPRO-39. The hypothesized correlations between similar constructs in the ThyPRO-39 and the SF-12v2 and SF-6D were generally observed, supporting convergent validity. The internal construct validity was supported in most items, except eight items in six scales. Scale score of hyperthyroid symptoms of the ThyPRO-39 was significantly higher in the group with Graves' disease or hyperthyroid disease than the group without Graves' disease nor hyperthyroid disease. Scale scores of eye symptoms and impaired daily life were significantly higher in the incidental group than the non-incidental group. For six domains (hyperthyroid symptoms, hypothyroid symptoms, eye symptoms, tiredness, depressivity, and emotional susceptibility), Cronbach's alpha did not reach the recommended standard of 0.7.
CONCLUSIONS: This was the first psychometric study to translate and adapt the ThyPRO-39 instrument for non-Caucasian patients, and report its validity and reliability for use in Chinese patients with benign thyroid diseases. Given the low item-total correlations in eight items and low internal consistency reliability in respective scales of the ThyPRO-39, we suggest that the improvement of those eight items should produce a more valid and reliable ThyPRO-39 instrument.

Entities:  

Keywords:  Chinese; Quality of life; ThyPRO; Thyroid

Mesh:

Year:  2018        PMID: 29671250     DOI: 10.1007/s11136-018-1857-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  31 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

Review 2.  Mode of questionnaire administration can have serious effects on data quality.

Authors:  Ann Bowling
Journal:  J Public Health (Oxf)       Date:  2005-05-03       Impact factor: 2.341

Review 3.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 4.  Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.

Authors:  Matthias Büttner; Thomas J Musholt; Susanne Singer
Journal:  Endocrine       Date:  2017-08-18       Impact factor: 3.633

5.  Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.

Authors:  Diane Wild; Alyson Grove; Mona Martin; Sonya Eremenco; Sandra McElroy; Aneesa Verjee-Lorenz; Pennifer Erikson
Journal:  Value Health       Date:  2005 Mar-Apr       Impact factor: 5.725

6.  Impaired health-related quality of life in Graves' disease. A prospective study.

Authors:  T V Elberling; A K Rasmussen; U Feldt-Rasmussen; M Hørding; H Perrild; G Waldemar
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

7.  Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis.

Authors:  T P Links; K M van Tol; P L Jager; J Th M Plukker; D A Piers; H M Boezen; R P F Dullaart; E G E de Vries; W J Sluiter
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

8.  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis.

Authors:  Ane Garmendia Madariaga; Silvia Santos Palacios; Francisco Guillén-Grima; Juan C Galofré
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

Review 9.  Quality of life in patients with benign thyroid disorders. A review.

Authors:  Torquil Watt; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Jakob Bue Bjorner; Ulla Feldt-Rasmussen
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

10.  Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO.

Authors:  Torquil Watt; Giuseppe Barbesino; Jakob Bue Bjorner; Steen Joop Bonnema; Branka Bukvic; Russell Drummond; Mogens Groenvold; Laszlo Hegedüs; Valeska Kantzer; Kathryn E Lasch; Claudio Marcocci; Anjali Mishra; Romana Netea-Maier; Merel Ekker; Ivan Paunovic; Terence J Quinn; Åse Krogh Rasmussen; Audrey Russell; Mayilvaganan Sabaretnam; Johannes Smit; Ove Törring; Vladan Zivaljevic; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2014-09-07       Impact factor: 4.147

View more
  3 in total

1.  Acupuncture for Hashimoto thyroiditis: study protocol for a randomized controlled trial.

Authors:  Shanze Wang; Jiping Zhao; Weimei Zeng; Wanqing Du; Tenghui Zhong; Hui Gao; Yi Xiao; Chao Yang
Journal:  Trials       Date:  2021-01-21       Impact factor: 2.279

2.  Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease.

Authors:  Huiling Liew; Torquil Watt; Luo Nan; Alvin W K Tan; Yiong Huak Chan; Daniel Ek Kwang Chew; Rinkoo Dalan
Journal:  J Patient Rep Outcomes       Date:  2021-07-08

3.  Validity and reliability of the German version of the shortened thyroid-specific quality of life questionnaire (ThyPRO-39de).

Authors:  Navid Tabriz; Kilian Gloy; Astrid Schantzen; Dennis Fried; Dirk Weyhe; Verena Uslar
Journal:  Endocr Connect       Date:  2021-09-01       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.